Leaflet: information for the user
Pure sterilized vaseline Orravan ointment
Read this leaflet carefully before you start using this medicine, because it contains important information for you.
Follow exactly the administration instructions of the medicine contained in this
leaflet or those indicated by your doctor or pharmacist.
A soothing ointment.
Pure Sterilized Vaseline Orravan is indicated for: Symptomatic relief of dry, cracked, and irritated skin. As a skin protector and softener due to its emollient properties (which soften).
Used by qualified healthcare personnel: As a lubricant in general for gynecological and rectal examinations, placement of catheters, and application of dressings.
Do not use Pure Sterilized Beeswax Orravan:
Warnings and precautions
Consult your doctor or pharmacist before using Pure Sterilized Beeswax Orravan.
Children and adolescents
This medication can be used on the skin of children.
In use for explorations, there are no available data for children.
Use of Pure Sterilized Beeswax Orravan with other medications
The use of this medication does not interact with the use of other medications.
Pregnancy and breastfeeding
This medication can be used during pregnancy on the skin.
Do not apply the medication to the breasts if breastfeeding a baby.
Driving and operating machines
Not applicable.
Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
The recommended dose is:
- On the skin: Apply a thin layer of vaseline to the affected area one to three times a day.
- In gynecological and rectal examinations (performed by qualified healthcare personnel): Apply a thin layer of the product to the friction area before the examination.
If you use more Pure Sterilized Vaseline Orravan than you should
No adverse effects have been reported when using a thin layer of vaseline on the skin.
With the use of excessive doses on mucous membranes (such as the nasal passages), leakage or aspiration may occur, resulting in adverse effects.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, Phone: 91 562 04 20, indicating the medication and the amount ingested (or visit a medical center).
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not all individuals will experience them.
Adverse reactions have occurred in rare instances in susceptible individuals.
Also reported are acne and inflammatory reactions following non-indicated use.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:www.notificaRAM.es
By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Store below 30°C.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Pure Sterilized Petroleum Jelly Composition Orravan
Product appearance and container content
The product is presented in the form of an ointment; it is whitish and greasy to the touch.
It is presented in an aluminum tube with a print containing 18 g, 25 g, or 32 g of ointment.
Marketing Authorization Holder
Reig Jofré, S.A. Laboratory
Gran Capitán Street, 10
08970 – Sant Joan Despí (Barcelona)
Spain
Responsible for Manufacturing
BIOGLAN AB
Box 503 10
SE-202 13 Malmö
Sweden
Last review date of this leaflet:November 2014.
Detailed and updated information about this medication is available on the
website of the Spanish Agency for Medicines and Medical Devices (AEMPS)
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.